Skip to main content
. 2019 Jul-Sep;6(3):277–282. doi: 10.4103/apjon.apjon_4_19

Table 4.

Scalp cooling success rate according to chemotherapy regimen

Parameter Participants No. (%) Anthracycline-Taxane***

Anthracycline* Taxane**
Success 40 (47) 49 (89) 47 (78)
Failure 45 (53) 6 (11) 13 (22)
Total 85 (100) 55 (100) 60 (100)

*AC, EC , FEC, DC. **Paclitaxel, docetaxel. ***AC followed paclitaxel, FEC followed docetaxel, EF followed by docetaxel